Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories

被引:16
|
作者
Scherphof, Charlotte S. [1 ]
van den Eijnden, Regina J. J. M. [1 ]
Lugtig, Peter [2 ]
Engels, Rutger C. M. E. [3 ]
Vollebergh, Wilma A. M. [1 ]
机构
[1] Univ Utrecht, NL-3508 TC Utrecht, Netherlands
[2] Univ Utrecht, Dept Methods & Stat, NL-3508 TC Utrecht, Netherlands
[3] Radboud Univ Nijmegen, Inst Behav Sci, NL-6500 HE Nijmegen, Netherlands
关键词
Compliance; Nicotine replacement therapy; Adolescents; Smoking cessation; LCGA; Personality; TARGETED INTERVENTIONS DELAY; MEDICATION ADHERENCE; TOBACCO DEPENDENCE; PERSONALITY; SMOKERS; SYMPTOMS; EFFICACY; BEHAVIOR; GROWTH; DRINKING;
D O I
10.1007/s00213-014-3511-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous research has shown limited efficacy of nicotine replacement therapy (NRT) among adolescents and generally low compliance rates. As higher compliance rates are associated with improved abstinence rates, the present study examined predictors of NRT compliance. This study aims to test whether different NRT compliance trajectories can be distinguished among adolescents, to test whether these trajectories can be predicted by demographic, smoking-related, and personality factors, and to examine abstinence rates for each trajectory. Data were used from a randomized controlled trial that tested the efficacy of nicotine patches versus placebo patches among 265 Dutch adolescents. During NRT treatment, adolescents filled out six online questionnaires in which they reported on the number of days they used the patches. Predictors (i.e., demographic and smoking-related factors and personality characteristics) and end-of-treatment abstinence were also administered through these self-reports. Latent class growth analysis (LCGA) was used to analyze compliance data by classifying individuals into similar growth trajectories. Three compliance trajectories were found (i.e., "compliers" (n = 89), "moderate decreasers" (n = 41), and "strong decreasers" (n = 127)). The compliers can be characterized by higher levels of conscientiousness and agreeableness and lower levels of extraversion compared with the strong decreasers, and by higher levels of conscientiousness and education compared with the moderate decreasers. Among the compliers, a substantially higher percentage of adolescents achieved abstinence at end-of-treatment (10 %) compared with the moderate decreasers (3 %) and the strong decreasers (6 %). These findings could be the starting point for person-tailored interventions that aim to enhance NRT compliance rates among adolescents.
引用
收藏
页码:1743 / 1752
页数:10
相关论文
共 50 条
  • [1] Adolescents’ use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories
    Charlotte S. Scherphof
    Regina J. J. M. van den Eijnden
    Peter Lugtig
    Rutger C. M. E. Engels
    Wilma A. M. Vollebergh
    Psychopharmacology, 2014, 231 : 1743 - 1752
  • [2] Nicotine replacement therapy as a smoking cessation tool for adolescents: an update
    Beis, Ioannis
    Dimou, Anastasios
    Kotoulas, Serafeim-Chrysovalantis
    Pataka, Athanasia
    FRONTIERS IN PSYCHIATRY, 2025, 16
  • [3] Nicotine replacement therapy for smoking cessation
    Stead, Lindsay F.
    Perera, Rafael
    Bullen, Chris
    Mant, David
    Hartmann-Boyce, Jamie
    Cahill, Kate
    Lancaster, Tim
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [4] Nicotine Replacement Therapy for Smoking Cessation
    Barry, Kathleen
    Finke, Jorge
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (01) : 17 - 18
  • [5] Nicotine replacement therapy in smoking cessation
    Campbell, I
    THORAX, 2003, 58 (06) : 464 - 465
  • [6] NICOTINE-REPLACEMENT THERAPY IN CESSATION OF SMOKING
    PETERS, JA
    MAYO CLINIC PROCEEDINGS, 1990, 65 (12) : 1619 - 1623
  • [7] Transdermal nicotine replacement smoking cessation therapy
    Setter, SM
    Johnson, MD
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (02) : 264 - 266
  • [8] Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
    Riju Ray
    Robert A. Schnoll
    Caryn Lerman
    CNS Drugs, 2007, 21 : 525 - 533
  • [9] ABC of smoking cessation - Nicotine replacement therapy
    Molyneux, AN
    BRITISH MEDICAL JOURNAL, 2004, 328 (7437): : 454 - 456
  • [10] Pharmacogenetics and smoking cessation with nicotine replacement therapy
    Ray, Riju
    Schnoll, Robert A.
    Lerman, Caryn
    CNS DRUGS, 2007, 21 (07) : 525 - 533